Clinical Trial Update: Tecovirimat in Non-hospitalized Patients With Monkeypox [Phase 3]

View source ↗

Summary

Tecovirimat is being studied in non-hospitalized monkeypox patients in a Phase 3 trial that has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Monkeypox

Drugs mentioned

• TPOXX (tecovirimat monohydrate)

Snippet

Sponsor: Marina Klein | Conditions: Monkeypox | Phase 3 | Status: SUSPENDED